p21 Downregulation is an important component of PAX3/FKHR oncogenicity and its reactivation by HDAC inhibitors enhances combination treatment. (Q39706036)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	p21 Downregulation is an important component of PAX3/FKHR oncogenicity and its reactivation by HDAC inhibitors enhances combination treatment.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20453878%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

p21 Downregulation is an important component of PAX3/FKHR oncogenicity and its reactivation by HDAC inhibitors enhances combination treatment (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20453878%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20453878%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20453878%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

R M Hecker

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20453878%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

R A Amstutz

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20453878%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

M Wachtel

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20453878%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

D Walter

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20453878%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

language of work or name

0 references

publication date

10 May 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20453878%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20453878%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

29

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20453878%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

27

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20453878%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

3942-3952

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20453878%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Phosphorylation regulates transcriptional activity of PAX3/FKHR and reveals novel therapeutic possibilities.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.145

21 January 2018

p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.145

21 January 2018

Superior activity of the combination of histone deacetylase inhibitor LAQ824 and the FLT-3 kinase inhibitor PKC412 against human acute myelogenous leukemia cells with mutant FLT-3.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.145

21 January 2018

Differentiation of rhabdomyosarcoma cell lines using retinoic acid

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.145

21 January 2018

Induction of apoptosis in rhabdomyosarcoma cells through down-regulation of PAX proteins.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.145

21 January 2018

Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma--a report from the Intergroup Rhabdomyosarcoma Study IV.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.145

21 January 2018

Addiction to elevated insulin-like growth factor I receptor and initial modulation of the AKT pathway define the responsiveness of rhabdomyosarcoma to the targeting antibody

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.145

21 January 2018

p21 Waf1/Cip1 expression by curcumin in U-87MG human glioma cells: role of early growth response-1 expression

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.145

21 January 2018

Comparative expression profiling identifies an in vivo target gene signature with TFAP2B as a mediator of the survival function of PAX3/FKHR

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.145

21 January 2018

Lost in transcription: p21 repression, mechanisms, and consequences

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.145

21 January 2018

Effects of PAX3-FKHR on malignant phenotypes in alveolar rhabdomyosarcoma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.145

21 January 2018

Strategies for silencing human disease using RNA interference

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.145

21 January 2018

Initial testing (stage 1) of a monoclonal antibody (SCH 717454) against the IGF-1 receptor by the pediatric preclinical testing program

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.145

21 January 2018

Transcription factor EGR-1 suppresses the growth and transformation of human HT-1080 fibrosarcoma cells by induction of transforming growth factor beta 1.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.145

21 January 2018

Rhabdomyosarcoma--working out the pathways

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.145

21 January 2018

Soft tissue sarcomas of childhood

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.145

21 January 2018

HDAC4 represses p21(WAF1/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.145

21 January 2018

p21Cip1 gene expression is modulated by Egr1: a novel regulatory mechanism involved in the resveratrol antiproliferative effect.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.145

21 January 2018

Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.145

21 January 2018

PAX3-FOXO1 controls expression of the p57Kip2 cell-cycle regulator through degradation of EGR1.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.145

21 January 2018

Guilt by association: PAX3-FOXO1 regulates gene expression through selective destabilization of the EGR1 transcription factor

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.145

21 January 2018

Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.145

21 January 2018

Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.145

21 January 2018

Divergent cytotoxic effects of PKC412 in combination with conventional antileukemic agents in FLT3 mutation-positive versus -negative leukemia cell lines.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.145

31 March 2020

Isolation of genes differentially expressed in human primary myoblasts and embryonal rhabdomyosarcoma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.145

31 March 2020

Transcriptional activation of p21(WAF1/CIP1) by apicidin, a novel histone deacetylase inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.145

31 March 2020

Survival after relapse in children and adolescents with rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.145

31 March 2020

Which patients with microscopic disease and rhabdomyosarcoma experience relapse after therapy? A report from the soft tissue sarcoma committee of the children's oncology group

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.145

31 March 2020

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39706036&oldid=2203111081"